Next-gen gene therapy vector for muscle diseases uses AI predictive methodology to improve efficacy and safety
A new study describes the use of artificial intelligence (AI) in designing a new generation of capsids, the structures that ...
biopharma-reporter1d
Cellevate bags €3.2 million to smash viral vector manufacturing bottleneck
The Swedish biotech company Cellevate has raised €3.2 million in a seed round to fuel the commercialization of its ...
The American Journal of Managed Care1d
Meta-Study Analyzes Immunosuppressive Protocols for AAV Gene Therapy for Monogenic Disorders
Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect ...
Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO
Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO Oxford, UK – 18 ...
BioSpace23h
4DMT’S Gene Therapy for AMD Clears Phase II, Heads to Late-Stage Studies
D Molecular Therapeutics reported its experimental gene therapy demonstrated a nearly 90% reduction in the need for ...
The EMBO Journal10d
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells
Co-expressing NPY and its inhibitory receptor Y2 in excitatory hippocampal cells allows inhibitory autoregulation of ...
GEN9d
Gene Therapy for Inherited Deafness Approaches a Threshold
Research successes are driving gene therapy for inherited deafness to the clinic, but commercialization efforts are needed to ...
ophthalmologytimes3d
Study: Gene therapy effective in hereditary blindness
Researchers at the Karolinska Institute continue to investigate whether gene therapy can improve vision in people with ...
Gene therapy found to be effective in hereditary blindness
Bothnia dystrophy is a form of hereditary blindness, prevalent in the region Västerbotten in Sweden. A new study at ...
Cell & Gene Therapy Manufacturing Services Market Size Worth US$ 70.7 Billion by 2032, Amid Rising Clinical Trials | Research by SNS Insider
The Cell & Gene Therapy Manufacturing Services market is driven by increasing investments in advanced therapies, rising ...
News Medical on MSN10d
SP-101 gene therapy shows promise for cystic fibrosis treatment
Scientists from Spirovant Sciences describe SP-101, a novel adeno-associated virus (AAV) gene therapy for the treatment of cystic fibrosis (CF) in the peer-reviewed journal Human Gene Therapy.